(VIANEWS) – NASDAQ Composite ended the session with Horizon Therapeutics (HZNP) jumping 2.06% to $96.17 on Wednesday while NASDAQ Composite jumped 0.92% to $14,631.95.


Today’s last reported volume for Horizon Therapeutics is 787327, 48.36% below its average volume of 1524720.

Horizon Therapeutics’s last close was $94.23, 4.17% below its 52-week high of $98.33.

Horizon Therapeutics’s Sales

Horizon Therapeutics’s sales growth is 48% for the present quarter and 72.5% for the next. The company’s growth estimates for the ongoing quarter is 120% and a drop 16.7% for the next.

Horizon Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 2.19B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Horizon Therapeutics’s stock is considered to be overbought (>=80).

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $96.17 at 19:00 EST, below its 52-week high of $98.33 and way higher than its 52-week low of $56.20.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s worth is above its 50-day moving average of $93.16 and higher than its 200-day moving average of $88.87.

More news about Horizon Therapeutics (HZNP).


Please enter your comment!
Please enter your name here